THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. Earnings Per Share (Diluted)
THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. reported Earnings Per Share (Diluted) of $0.00 per share for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-20.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2024-11-20
- THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. earnings per share, diluted for the quarter ending 2024-09-30 was $0.00.
- THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. earnings per share, diluted for the quarter ending 2024-06-30 was $0.00.
- THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. earnings per share, diluted for the quarter ending 2024-03-31 was $0.00.
- THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. earnings per share, diluted for the quarter ending 2023-12-31 was -$0.00.
- THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. earnings per share, diluted for fiscal 2023 was $0.00.
- THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. earnings per share, diluted for fiscal 2022 was $0.00.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|
| 2024-09-30 | $0.00 10-Q · filed 2024-11-20 | -$0.00 derived: net income ÷ weighted average shares · filed 2024-11-20 | $0.00 10-Q · filed 2024-11-20 | -$0.00 derived: net income ÷ weighted average shares · filed 2024-11-20 |
| 2024-06-30 | $0.00 10-Q · filed 2024-08-19 | $0.00 10-Q · filed 2024-08-19 | -$0.00 derived: net income ÷ weighted average shares · filed 2024-08-19 | -$0.00 derived: net income ÷ weighted average shares · filed 2024-11-20 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-30 | -$0.00 derived: net income ÷ weighted average shares · filed 2024-05-30 | -$0.00 derived: net income ÷ weighted average shares · filed 2024-11-20 | -$0.00 derived: net income ÷ weighted average shares · filed 2024-11-20 |
| 2023-12-31 | -$0.00 derived: net income ÷ weighted average shares · filed 2024-04-17 | -$0.00 derived: net income ÷ weighted average shares · filed 2024-11-20 | -$0.00 derived: net income ÷ weighted average shares · filed 2024-11-20 | $0.00 10-K · filed 2024-04-17 |
| 2023-09-30 | $0.00 10-Q · filed 2024-11-20 | -$0.00 derived: net income ÷ weighted average shares · filed 2024-11-20 | $0.00 10-Q · filed 2024-11-20 | -$0.00 derived: net income ÷ weighted average shares · filed 2024-11-20 |
| 2023-06-30 | $0.00 10-Q · filed 2024-08-19 | $0.00 10-Q · filed 2024-08-19 | -$0.00 derived: net income ÷ weighted average shares · filed 2024-08-19 | -$0.00 derived: net income ÷ weighted average shares · filed 2024-08-19 |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-30 | -$0.00 derived: net income ÷ weighted average shares · filed 2024-05-30 | -$0.00 derived: net income ÷ weighted average shares · filed 2024-05-30 | -$0.00 derived: net income ÷ weighted average shares · filed 2024-05-30 |
| 2022-12-31 | -$0.00 derived: net income ÷ weighted average shares · filed 2024-04-17 | -$0.00 derived: net income ÷ weighted average shares · filed 2024-04-17 | -$0.00 derived: net income ÷ weighted average shares · filed 2024-04-17 | $0.00 10-K · filed 2024-04-17 |
| 2022-09-30 | $0.00 10-Q · filed 2023-11-14 | -$0.00 derived: net income ÷ weighted average shares · filed 2023-11-14 | $0.00 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $0.00 10-Q · filed 2023-08-21 | $0.00 10-Q · filed 2023-08-21 | ||
| 2021-03-31 | -$0.00 derived: net income ÷ weighted average shares · filed 2022-05-23 | |||
| 2020-03-31 | $0.00 10-Q/A · filed 2020-07-09 | |||
| 2019-03-31 | $0.00 derived: net income ÷ weighted average shares · filed 2021-05-21 | |||
| 2018-03-31 | $0.00 10-Q/A · filed 2020-07-09 |